Perspectiva general
DIA India aims to provide a dynamic and comprehensive overview of the journey from bench to bedside, drug design with DMPK, artificial intelligence in preclinical development, implementing effective Phase I strategies, starting stronger at proof of concept and leveraging Phase IIa data to plan for a smarter and faster Phase III trial.
Featured
Want to learn more about DIA India New Paradigms in Translational Research and Early Phase Development? You've come to the right site!
Comité del programa
-
Manjunath Ramarao Group Director and Head Discovery Biology and Translational Sciences
Bristol-Myers Squibb, India -
Sonica Sachdeva Batra, MD Associate Vice President Enterprise Medical;Global Head- Regulatory Affairs
Indegene Ltd., India -
Kiran Marthak, MD, FFPM, FRCP Director, Phase 1 & Regulatory
Lambda Therapeutic Research Ltd., India -
Ammar Raza Country Medical Director
Allergan, India -
Charu Gautam, MD Senior Director- Medical Science and Strategy
IQVIA, India -
Jagannath Kota Associate Director, PK Sciences
Novartis, India
¿Tiene una cuenta?